These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 22007770

  • 1. Invadopodia proteins, cortactin and membrane type I matrix metalloproteinase (MT1-MMP) are expressed in ameloblastoma.
    Pinheiro JJ, Nascimento CF, Freitas VM, de Siqueira AS, Junior SM, Jaeger RG.
    Histopathology; 2011 Dec; 59(6):1266-9. PubMed ID: 22007770
    [No Abstract] [Full Text] [Related]

  • 2. Invadopodia proteins, cortactin, N-WASP and WIP differentially promote local invasiveness in ameloblastoma.
    Siar CH, Rahman ZA, Tsujigiwa H, Mohamed Om Alblazi K, Nagatsuka H, Ng KH.
    J Oral Pathol Med; 2016 Sep; 45(8):591-8. PubMed ID: 26752341
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
    Siqueira AS, Carvalho MR, Monteiro AC, Freitas VM, Jaeger RG, Pinheiro JJ.
    Histopathology; 2010 Jul; 57(1):128-37. PubMed ID: 20653784
    [Abstract] [Full Text] [Related]

  • 4. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES, Whigham AS, Yarbrough WG, Weaver AM.
    Cancer Res; 2007 May 01; 67(9):4227-35. PubMed ID: 17483334
    [Abstract] [Full Text] [Related]

  • 5. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
    Mitre GP, Balbinot KM, Ribeiro ALR, da Silva Kataoka MS, de Melo Alves Júnior S, de Jesus Viana Pinheiro J.
    Diagn Pathol; 2021 Apr 20; 16(1):33. PubMed ID: 33879222
    [Abstract] [Full Text] [Related]

  • 6. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.
    Zhang B, Zhang J, Huang HZ, Xu ZY, Xie HL.
    J Oral Pathol Med; 2010 Mar 20; 39(3):219-22. PubMed ID: 19709349
    [Abstract] [Full Text] [Related]

  • 7. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC.
    Cancer Res; 2006 Mar 15; 66(6):3034-43. PubMed ID: 16540652
    [Abstract] [Full Text] [Related]

  • 8. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity.
    Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG.
    Histopathology; 2004 Jul 15; 45(1):65-72. PubMed ID: 15228445
    [Abstract] [Full Text] [Related]

  • 9. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.
    Zhang B, Zhang J, Xu ZY, Xie HL.
    BMC Cancer; 2009 Dec 08; 9():427. PubMed ID: 19995435
    [Abstract] [Full Text] [Related]

  • 10. Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP).
    Wang X, Wilson MJ, Slaton JW, Sinha AA, Ewing SL, Pei D.
    J Androl; 2009 Dec 08; 30(3):259-74. PubMed ID: 19136391
    [Abstract] [Full Text] [Related]

  • 11. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
    Souza Andrade ES, da Costa Miguel MC, Pinto LP, de Souza LB.
    Ann Diagn Pathol; 2007 Jun 08; 11(3):199-205. PubMed ID: 17498594
    [Abstract] [Full Text] [Related]

  • 12. [The study of the invasive biologic behavior of ameloblastoma].
    Zhong M, Li ZJ, Wang J, Yue YL, Bao G.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan 08; 39(1):45-8. PubMed ID: 14989873
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of matrix metalloproteinases in ameloblastomas and pericoronal follicles.
    Dutra KL, Cordeiro MM, Vieira DS, Rivero ER.
    J Oral Pathol Med; 2016 Sep 08; 45(8):586-90. PubMed ID: 26694521
    [Abstract] [Full Text] [Related]

  • 14. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.
    Ida-Yonemochi H, Ahsan MS, Saku T.
    Histopathology; 2011 Jan 08; 58(2):234-45. PubMed ID: 21255062
    [Abstract] [Full Text] [Related]

  • 15. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
    Sathi GS, Nagatsuka H, Tamamura R, Fujii M, Gunduz M, Inoue M, Rivera RS, Nagai N.
    Histopathology; 2008 Oct 08; 53(4):458-67. PubMed ID: 18983611
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
    Florescu A, Mărgăritescu C, Simionescu CE, Stepan A.
    Rom J Morphol Embryol; 2012 Oct 08; 53(4):975-84. PubMed ID: 23303021
    [Abstract] [Full Text] [Related]

  • 17. [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma].
    Jiang LJ, Shao CK, He D, Li WG, Wu XZ, Cai DZ.
    Ai Zheng; 2008 Dec 08; 27(12):1263-6. PubMed ID: 19079990
    [Abstract] [Full Text] [Related]

  • 18. Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters.
    Scheper MA, Duarte EC, Intapa C, Zhang M, Nascimento LM, Almeida TP, Gomes AC, Song S, Chaisuparat R, Batista AC, Jham BC.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct 08; 114(4):497-502. PubMed ID: 22986245
    [Abstract] [Full Text] [Related]

  • 19. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R, Lizárraga F, Chavrier P.
    J Cell Sci; 2009 Sep 01; 122(Pt 17):3015-24. PubMed ID: 19692588
    [Abstract] [Full Text] [Related]

  • 20. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC, Lequerica-Fernández P, Santamaría J, Fresno MF.
    J Oral Pathol Med; 2007 Aug 01; 36(7):415-24. PubMed ID: 17617835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.